Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

FromThe Exchange


Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

FromThe Exchange

ratings:
Length:
47 minutes
Released:
May 27, 2020
Format:
Podcast episode

Description

Another rally on Wall Street and two strategists both say there’s more room to run…where they’re finding opportunities.The CEO of AbCellera joins to discuss the company’s partnership with Eli Lilly in the race for a COVID-19 antibody drug.And two policy strategists weigh in one of the biggest and most underappreciated risks for the market right now.Plus, a ‘cool’ trade for the summer.
Released:
May 27, 2020
Format:
Podcast episode